A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC (NCT06699121)
A Phase 2 Randomized, Double Blind, Placebo Controlled, Parallel Study Evaluating the Safety and Efficacy of LB P8 in Patients With Primary Sclerosing Cholangitis (PSC)
🩺 Plain-English Summary (8th-Grade Level)
The study is designed to assess the safety and efficacy of LB-P8 in patients with primary sclerosing cholangitis.
Who can join: Review the eligibility criteria below.
Location: University of California Davis — Sacramento, California
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (7 Sites)
- University of California Davis — Sacramento, California
- UCHealth University of Colorado Hospital — Aurora, Colorado
- University Of Iowa Hospitals And Clinics — Iowa City, Iowa
- Mercy Medical Center — Baltimore, Maryland
- Mayo Clinic — Rochester, Minnesota
- The Vanderbilt Clinic — Nashville, Tennessee
- Liver institute Northwest — Seattle, Washington
📞 Contact the Study Coordinator
Phone: +82317061710
Email: clinical@liscure.bio
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Primary Sclerosing Cholangitis (PSC) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.